Skip to main content
Go to the home page of the European Commission (opens in new window)
English en
CORDIS - EU research results
CORDIS

A modular sensing and imaging toolkit for the early diagnosis of prostate cancer employing lab-on-the-chip methodologies

Project description

Innovative sensors for early prostate cancer diagnosis

In Europe, prostate cancer (PCa) is one of the most frequent cancer diagnoses in men. Since PCa is usually asymptomatic in the early stages, there is a worrying trend of late diagnosis. Low levels of cellular cancer biomarkers as prostate-specific membrane antigen are present in blood up to five years before diagnosis. However, existing PCa screening methods lack sufficient sensitivity for the early diagnosis of circulating cancerous cells. The EU-funded Tools-To-Sense project will develop fast and reliable methods based on electrochemical or optical sensing. The project will integrate chemical sensors into innovative sensing devices tailored to target PCa cells for molecular imaging applications to assess circulating PCa cell concentration.

Objective

This Proof-of-concept project will focus on the innovative exploitation of new diagnostic sensor prototypes which will tackle the early diagnosis of prostate cancer (PCa), one of the greatest concerns for ageing men worldwide.
The development of fast and reliable methods for detecting PCa by electrochemical or optical biosensing will address the unmet need for an early diagnosis and for monitoring non-invasively the PCa evolution post-diagnosis.
Current PCa screening methods detect the prostate-specific antigen (PSA) by enzyme-linked immunosorbent assays (ELISA), but struggle to achieve detection limits below 1 ng/ml. This level of sensitivity is insufficient for the detection of circulating cancerous cells before symptoms of the disease appear: low levels of cellular cancer biomarkers such as PSMA (Prostate-specific membrane antigen) are present in blood up to 5 years before diagnosis.
More accurate sensors interfaced with an actuator in sensing devices using lab-on-the-chip and applicable in ‘real-time’ will be devised hereby. The innovative prototypes of Tools-To-Sense will incorporate the chemical sensors already available through the underlining ERC Consolidator Grant O2Sense, which are tailored to target PCa cells for molecular imaging applications. These will be able to estimate the concentration of circulating PCa cells as the complex analyte under interrogation. We will focus on target identification and validation, bioassay development and quality control for early detection of PCa using nanotechnology. Biosensors incorporating peptides-functionalised graphene substrates will be assembled since field-effect transistors can achieve high sensitivity for the detection of a panel of PCa biomarkers. New biosensors incorporating dedicated molecular species that provide information about their chemical environment by generating a physical signal consisting of a combined electrochemical and fluorescence emission will be homologated by Tools-To-Sense.

Fields of science (EuroSciVoc)

Programme(s)

Topic(s)

Funding Scheme

ERC-POC-LS - ERC Proof of Concept Lump Sum Pilot

See all projects funded under this funding scheme

Call for proposal

(opens in new window) ERC-2020-PoC

See all projects funded under this call

Host institution

UNIVERSITY OF BATH
Net EU contribution
€ 150 000,00
Address
CLAVERTON DOWN
BA2 7AY BATH
United Kingdom
Region
South West (England) Gloucestershire, Wiltshire and Bristol/Bath area Bath and North East Somerset, North Somerset and South Gloucestershire
Activity type
Higher or Secondary Education Establishments
Links
Total cost
No data

Beneficiaries (1)